Sunday, 7 January 2018

Pfizer ends research for new Alzheimer's, Parkinson's drugs

NEW YORK (Reuters) - Pfizer Inc is abandoning research to find new drugs aimed at treating Alzheimer's and Parkinson's disease, the U.S. pharmaceutical company announced on Saturday.


No comments:

Post a Comment